Generate Biomedicines Statistics

Total Valuation

GENB has a market cap or net worth of $2.11 billion. The enterprise value is $1.66 billion.

Market Cap	2.11B
Enterprise Value	1.66B

Important Dates

The next estimated earnings date is Monday, August 3, 2026, after market close.

Earnings Date	Aug 3, 2026
Ex-Dividend Date	n/a

Share Statistics

GENB has 128.19 million shares outstanding.

Current Share Class	128.19M
Shares Outstanding	128.19M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+97.83%
Owned by Insiders (%)	4.08%
Owned by Institutions (%)	23.54%
Float	60.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	69.68
Forward PS	100.06
PB Ratio	4.10
P/TBV Ratio	4.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	54.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.17, with a Debt / Equity ratio of 0.13.

Current Ratio	9.17
Quick Ratio	8.85
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-264.23

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-44.24%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$97,112
Profits Per Employee	-$850,772
Employee Count	312
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, GENB has paid $135,000 in taxes.

Income Tax	135,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	13.74
200-Day Moving Average	n/a
Relative Strength Index (RSI)	64.05
Average Volume (20 Days)	1,126,755

Short Selling Information

The latest short interest is 4.09 million, so 3.19% of the outstanding shares have been sold short.

Short Interest	4.09M
Short Previous Month	3.45M
Short % of Shares Out	3.19%
Short % of Float	6.78%
Short Ratio (days to cover)	7.08

Income Statement

In the last 12 months, GENB had revenue of $30.30 million and -$265.44 million in losses. Loss per share was -$4.57.

Revenue	30.30M
Gross Profit	-205.39M
Operating Income	-251.02M
Pretax Income	-240.23M
Net Income	-265.44M
EBITDA	-238.09M
EBIT	-251.02M
Loss Per Share	-$4.57

Full Income Statement

Balance Sheet

The company has $516.64 million in cash and $65.57 million in debt, giving a net cash position of $451.07 million or $3.52 per share.

Cash & Cash Equivalents	516.64M
Total Debt	65.57M
Net Cash	451.07M
Net Cash Per Share	$3.52
Equity (Book Value)	514.80M
Book Value Per Share	4.02
Working Capital	477.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$227.83 million and capital expenditures -$6.54 million, giving a free cash flow of -$234.38 million.

Operating Cash Flow	-227.83M
Capital Expenditures	-6.54M
Depreciation & Amortization	12.94M
Net Borrowing	-6.63M
Free Cash Flow	-234.38M
FCF Per Share	-$1.83

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-828.49%
Pretax Margin	-792.86%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GENB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-12.57%
FCF Yield	-11.10%

Analyst Forecast

The average price target for GENB is $25.40, which is 54.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.40
Price Target Difference	54.22%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (3Y)	42.47%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GENB has an Altman Z-Score of 6.41 and a Piotroski F-Score of 1.

Altman Z-Score	6.41
Piotroski F-Score	1